ARROWHEAD PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$162M, a 49.7% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$601M, a 193% decline year-over-year.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was -$601M, a 193% decline from 2023.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$205M, a 14.8% decline from 2022.
  • Arrowhead Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 19.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$601M -$162M -$53.9M -49.7% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-26
Q2 2024 -$547M -$176M -$73.4M -71.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$474M -$126M -$174M -362% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$299M -$137M -$94.4M -224% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 -$205M -$108M -$24.5M -29.2% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-26
Q2 2023 -$181M -$103M -$29.8M -40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$151M $48.2M +$6.61M +15.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$157M -$42.1M +$21.2M +33.5% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q3 2022 -$179M -$83.8M -$18.9M -29.2% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-26
Q2 2022 -$160M -$72.9M -$41M -129% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$119M $41.6M +$69.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$188M -$63.3M -$39.3M -163% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-06
Q3 2021 -$149M -$64.9M -$14.8M -29.5% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-29
Q2 2021 -$134M -$31.9M -$15.9M -99.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$118M -$28.2M -$5.99M -26.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$112M -$24.1M -$19.2M -396% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-02
Q3 2020 -$93.2M -$50.1M -$59.8M -620% Jul 1, 2020 Sep 30, 2020 10-K 2020-11-23
Q2 2020 -$33.4M -$15.9M -$34.5M -186% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $1.14M -$22.2M -$44.3M -201% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $45.4M -$4.85M -$15.8M -144% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-04
Q3 2019 $61.2M $9.64M +$20.8M Jul 1, 2019 Sep 30, 2019 10-K 2020-11-23
Q2 2019 $40.4M $18.6M +$34.5M Apr 1, 2019 Jun 30, 2019 10-K 2020-11-23
Q1 2019 $5.87M $22M +$37M Jan 1, 2019 Mar 31, 2019 10-K 2020-11-23
Q4 2018 -$31.2M $10.9M +$24.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-11-23
Q3 2018 -$55.9M -$11.2M -$919K -8.97% Jul 1, 2018 Sep 30, 2018 10-K 2019-11-25
Q2 2018 -$55M -$15.9M -$10.2M -179% Apr 1, 2018 Jun 30, 2018 10-K 2019-11-25
Q1 2018 -$44.8M -$15M -$8.9M -145% Jan 1, 2018 Mar 31, 2018 10-K 2019-11-25
Q4 2017 -$35.9M -$13.8M +$1.09M +7.31% Oct 1, 2017 Dec 31, 2017 10-K 2019-11-25
Q3 2017 -$37M -$10.3M +$11.5M +53% Jul 1, 2017 Sep 30, 2017 10-K 2018-12-11
Q2 2017 -$48.5M -$5.71M +$13.6M +70.5% Apr 1, 2017 Jun 30, 2017 10-K 2018-12-11
Q1 2017 -$62.2M -$6.13M +$15.1M +71.2% Jan 1, 2017 Mar 31, 2017 10-K 2018-12-11
Q4 2016 -$77.3M -$14.9M +$4.44M +23% Oct 1, 2016 Dec 31, 2016 10-K 2018-12-11
Q3 2016 -$81.7M -$21.8M +$3.44M +13.6% Jul 1, 2016 Sep 30, 2016 10-K 2017-12-12
Q2 2016 -$85.2M -$19.3M -$3.35M -20.9% Apr 1, 2016 Jun 30, 2016 10-K 2017-12-12
Q1 2016 -$81.8M -$21.3M +$8.37M +28.2% Jan 1, 2016 Mar 31, 2016 10-K 2017-12-12
Q4 2015 -$90.2M -$19.3M +$5.77M +23% Oct 1, 2015 Dec 31, 2015 10-K 2017-12-12
Q3 2015 -$96M -$25.2M -$2.88M -12.9% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 -$93.1M -$16M -$3.29M -25.9% Apr 1, 2015 Jun 30, 2015 10-K 2016-12-14
Q1 2015 -$89.8M -$29.6M -$18.4M -164% Jan 1, 2015 Mar 31, 2015 10-K 2016-12-14
Q4 2014 -$71.4M -$25.1M -$18.1M -258% Oct 1, 2014 Dec 31, 2014 10-K 2016-12-14
Q3 2014 -$53.3M -$22.4M -$14.4M -179% Jul 1, 2014 Sep 30, 2014 10-K 2015-12-14
Q2 2014 -$38.9M -$12.7M -$6.31M -98.8% Apr 1, 2014 Jun 30, 2014 10-K 2015-12-14
Q1 2014 -$32.6M -$11.2M -$5.82M -108% Jan 1, 2014 Mar 31, 2014 10-K 2015-12-14
Q4 2013 -$26.8M -$7.01M -$2.2M -45.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-12-14
Q3 2013 -$24.6M -$8M -$2.62M -48.7% Jul 1, 2013 Sep 30, 2013 10-K 2014-11-25
Q2 2013 -$22M -$6.39M +$413K +6.07% Apr 1, 2013 Jun 30, 2013 10-K 2014-11-25
Q1 2013 -$22.4M -$5.39M -$522K -10.7% Jan 1, 2013 Mar 31, 2013 10-K 2014-11-25
Q4 2012 -$21.9M -$4.81M -$771K -19.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-11-25
Q3 2012 -$21.1M -$5.38M -$2.47M -84.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-11-25
Q2 2012 -$18.6M -$6.8M -$5.03M -284% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$13.6M -$4.87M -$3.06M -169% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$10.5M -$4.04M -$703K -21.1% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$9.83M -$2.91M Jul 1, 2011 Sep 30, 2011 10-K 2012-12-28
Q2 2011 -$1.77M -$379K -27.2% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$1.81M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 -$3.34M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-09
Q2 2010 -$1.39M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.